Patent classifications
C
CHEMISTRY; METALLURGY
Load children
C12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Load children
C12N
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
Load children
C12N2760/16211
Influenzavirus B, i.e. influenza B virus
Load children Filter patents View analytics View as hierarchy Open in page
C12N2760/16233
Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Filter patents View analytics View as hierarchy Open in page

C12N2760/16233

Use of immune suppressive domains as medicaments
11484567 · 2022-11-01 · ·

The present invention concerns uses of immune suppressive domains. In particular, the present invention concerns a use of an immune suppressive domain (ISD) for immune suppression and for reduction of inflammation.

Use of Immune Suppressive Domains as Medicaments
20230141663 · 2023-05-11 ·

The present invention concerns uses of immune suppressive domains. In particular, the present invention concerns a use of an immune suppressive domain (ISD) for immune suppression and for reduction of inflammation.

VIRAL DELIVERY OF A SIALIDASE TO TREAT CANCER
20240299582 · 2024-09-12 · ·

The present invention relates to adenovirus-associated virus comprising an influenza-derived neuraminidase transgene, used alone or together with an immune checkpoint inhibitor to treat a patient diagnosed with a solid cancer.